Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Escitalopram × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Depression 5 Depressive Disorder, Major 3 Polycystic Ovary Syndrome 2 Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Hot Flashes 1 Head and Neck Neoplasms 1 Glioma 1 Gallbladder Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 ENT Cancer 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Bile Duct Neoplasms 1 Behavior, Addictive 1 Asthma 1

Interventions

pembrolizumab 131 Gemcitabine 116 Capecitabine 110 Fluorouracil 101 Paclitaxel 100 Bevacizumab 94 Oxaliplatin 91 Nivolumab 88 Leucovorin 83 Docetaxel 83 Radiosurgery 80 Irinotecan 72 Carboplatin 72 Cisplatin 70 Cetuximab 62 Magnetic Resonance Spectroscopy 61 Cyclophosphamide 60 Specimen Handling 55 Biopsy 54 Trastuzumab 48 Radiotherapy 48 Drug Therapy 45 Ipilimumab 44 Everolimus 40 Pemetrexed 38 130-nm albumin-bound paclitaxel 38 Albumin-Bound Paclitaxel 37 Fulvestrant 36 Doxorubicin 34 aldesleukin 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04763135 2023-06-08

MIR-P

Hospices Civils de Lyon

Phase 3 Terminated

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡